Explores BBB dysfunction and gut microbiota impacts on Parkinson's disease, suggesting new therapeutic strategies.
Key Points
The study aims to summarize the relationship between blood-brain barrier dysfunction and gut microbiota dysbiosis in Parkinson’s disease and explore possible therapeutic approaches.
Reviewed existing literature on BBB integrity and gut microbiota in Parkinson’s disease.
Analyzed interactions between neuroinflammatory responses and gut microbiota composition.
Established a connection between blood-brain barrier disruption and gut microbiota dysbiosis in Parkinson’s disease.
Identified the role of inflammatory mediators in promoting BBB dysfunction and PD progression.